Repositioning and characterization of 1‑(Pyridin-4-yl)pyrrolidin-2- one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors (2021)
- Authors:
- USP affiliated authors: GUIDO, RAFAEL VICTÓRIO CARVALHO - IFSC ; AGUIAR, ANNA CAROLINE CAMPOS - IFSC
- Unidade: IFSC
- DOI: 10.1021/acsinfecdis.1c00020
- Subjects: PLASMODIUM; MALÁRIA; ANTIMALÁRICOS; ANTIPARASITÁRIOS
- Keywords: Malaria; Plasmodium; Prolyl-tRNA synthetase; PRS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Washington, DC
- Date published: 2021
- Source:
- Título: ACS Infectious Diseases
- ISSN: 2373-8227
- Volume/Número/Paginação/Ano: v. 7, n. 6, p. 1680-1689, June 2021
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by-nc-nd
-
ABNT
OKANIWA, Masanori e AGUIAR, Anna Caroline Campos e GUIDO, Rafael Victorio Carvalho. Repositioning and characterization of 1‑(Pyridin-4-yl)pyrrolidin-2- one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors. ACS Infectious Diseases, v. 7, n. 6, p. 1680-1689, 2021Tradução . . Disponível em: https://doi.org/10.1021/acsinfecdis.1c00020. Acesso em: 15 out. 2024. -
APA
Okaniwa, M., Aguiar, A. C. C., & Guido, R. V. C. (2021). Repositioning and characterization of 1‑(Pyridin-4-yl)pyrrolidin-2- one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors. ACS Infectious Diseases, 7( 6), 1680-1689. doi:10.1021/acsinfecdis.1c00020 -
NLM
Okaniwa M, Aguiar ACC, Guido RVC. Repositioning and characterization of 1‑(Pyridin-4-yl)pyrrolidin-2- one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors [Internet]. ACS Infectious Diseases. 2021 ; 7( 6): 1680-1689.[citado 2024 out. 15 ] Available from: https://doi.org/10.1021/acsinfecdis.1c00020 -
Vancouver
Okaniwa M, Aguiar ACC, Guido RVC. Repositioning and characterization of 1‑(Pyridin-4-yl)pyrrolidin-2- one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors [Internet]. ACS Infectious Diseases. 2021 ; 7( 6): 1680-1689.[citado 2024 out. 15 ] Available from: https://doi.org/10.1021/acsinfecdis.1c00020 - Fighting Plasmodium chloroquine resistance with acetylenic chloroquine analogues
- Aryl benzimidazoles: a new lead in malaria drug discovery
- Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome
- [1-7-NαC]-Crocaorb A1 and A2, orbitides from the latex of Croton campanulatus
- Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183
- Potent antimalarials with development potential identified by structure-guided computational optimization of a pyrrole-based dihydroorotate dehydrogenase inhibitor series
- Estudo do efeito de um grupo espaçador metilênico em marinoquinolinas: síntese e avaliação biológica
- Descoberta de derivados de marinoquinolina como inibidores de Plasmodium falciparum
- Descoberta de derivados de marinoquinolina como inibidores de Plasmodium falciparum
- New pyrazolopyrimidine and triazolopyrimidine derivatives with potential activity anti-P. falciparum
Informações sobre o DOI: 10.1021/acsinfecdis.1c00020 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | PROD031597_3032789.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
